COVID-19: Information on ASPIRA LABS Operations

Click to Learn More
  • Home
  • Hereditary Cancer Genetic Testing

Hereditary Cancer Genetic Testing

Learn more about your risk with Hereditary Cancer Genetic Testing


Identifying your genetic risk is important for cancer prevention, detection, and treatment.

Know Your Risk

Women and men with a hereditary cancer mutation have a higher chance of developing cancer, especially at a younger age. These mutations can be identified through genetic testing even before cancer develops.

Genetic Counseling is available both before and after testing is performed.

One in 78 women will develop ovarian cancer in her lifetime, or approximately 1.3 percent. This cancer is often detected at an advanced stage, making it especially important to identify individuals who may be at increased risk.

Would I benefit from genetic testing?

You may benefit from genetic testing for hereditary cancer if:

  • There is a known cancer-risk mutation in your family
  • You have a personal or family history of a specific cancer
  • You have a personal and/or family history of multiple cancers in a single individual
  • You are at increased ethnic risk (such as Ashkenazi Jewish for breast or ovarian cancer)
  • You have a family history of three or more individuals with breast, prostate, pancreatic, melanoma, or other cancers, especially if early-onset

Hereditary Cancer Diseases Offered:

With a focus on women’s health, ASPiRA LABS® offers both comprehensive and targeted genetic testing in several areas:

  • Ovarian Cancer
  • Breast Cancer
  • Endometrial Cancer

Quick Facts

  • Results are available in 2-3 weeks
  • Testing may provide more information to your doctor.
  • Testing may help define the best management plan for you.
  • If you are found to be a carrier of a condition, your family members may also be at risk.
  • Genetic counseling is available both before and after testing is performed.
  • The Genetic Information Nondiscrimination Act (GINA) protects individuals from discrimination based on genetic testing results and genetic information